15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky's RA Capital
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | RA Capital Management Peter Kolchinsky | 22,748,880 | $22,748,880 | 0.3% | |
2. | Laurion Capital Management Benjamin A. Smith | 2,525,449 | $2,525,449 | -21% | 0.02% |
3. | Sarissa Capital Management Alex Denner | 618,000 | $618,000 | 0.1% | |
4. | Renaissance Technologies Jim Simons | 495,300 | $495,300 | +49% | 0% |
5. | Millennium Management Israel Englander | 389,638 | $389,638 | +146% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$18.00 | 130,970 | Large Shareholder, Director | 1,825,326 | 2021-02-09 | Filing | |
$18.00 | 2,848,596 | Large Shareholder, Director | 8,297,265 | 2021-02-09 | Filing | |
$18.00 | 444,444 | Large Shareholder | 1,858,470 | 2021-02-09 | Filing | |
$18.00 | 111,111 | Large Shareholder | 4,833,959 | 2021-02-09 | Filing | |
$18.00 | 444,444 | Large Shareholder, Director | 1,858,470 | 2021-02-09 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.39 | 14,645 | 96,063 | 2024-06-03 | Filing | ||
$15.30 | 91,836 | Large Shareholder | 1,766,634 | 2021-11-16 | Filing | |
$15.30 | 238,870 | Large Shareholder | 4,595,089 | 2021-11-16 | Filing | |
$15.30 | 91,836 | Large Shareholder, Director | 1,766,634 | 2021-11-16 | Filing | |
$15.30 | 238,870 | Large Shareholder, Director | 4,595,089 | 2021-11-16 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 7,618,948 | $17,142,633 | 0% | |
2. | 6,457,293 | $14,528,909 | 0.68% | |
3. | 6,361,723 | $14,313,877 | 3.79% | |
4. | 2,251,411 | $5,065,674 | 0% | |
5. | 1,743,463 | $3,922,793 | 0% |